Skip to main content

Table 3 Univariable analysis and cox proportional hazards regression analysis

From: An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy

Variable

Univariable analysis

Multivariable analysis

Hazard ratio

95% CI

P

Hazard ratio

95% CI

P

Age

1.388

1.112–1.733

0.004

1.649

1.306–2.081

<0.001

Gender

 Female

R

     

 Male

1.243

0.965–1.601

0.092

   

Smoking history

 N

R

     

 Y

1.426

1.120–1.815

0.004

1.157

0.878–1.524

0.300

pT category

 T1–2

R

  

R

 

0.007

 T3–4

2.030

1.558–2.645

<0.001

1.455

1.097–1.930

0.009

pN category

 N0

R

 

<0.001

R

 

<0.001

 N1

2.414

1.808–3.22

<0.001

2.277

1.690–3.067

<0.001

 N2

4.097

3.153–5.323

<0.001

4.233

3.216–5.570

<0.001

 N3

6.170

1.953–19.493

0.002

5.121

1.530–17.144

0.008

Histology

 Histology ADC

R

  

R

  

 Histology CC

1.311

1.050–1.636

0.017

0.965

0.744–1.252

0.789

PGTD

 PGTD I

R

 

<0.001

R

 

0.008

 PGTD II

0.174

0.091–0.332

<0.001

2.671

1.433–4.979

0.002

 PGTD III

0.789

0.594–1.049

0.103

2.563

1.315–4.999

0.006

Chemotherapy

 N

R

     

 Y

1.166

0.934–1.457

0.175

   

NLR

 <3.1

R

     

 >3.1

1.845

1.457–2.337

<0.001

1.648

1.010–2.687

0.045

dNLR

 <0.499

R

     

 >0.499

0.627

0.497–0.790

<0.001

1.470

0.936–2.309

0.095

PLR

 <170.58

R

     

 >170.58

1.636

1.284–2.085

<0.001

1.201

0.895–1.621

0.221

LMR

 <3.53

R

     

 >3.53

0.619

0.496–0.772

<0.001

1.020

0.770–1.351

0.890

SII

 <781.82

R

     

 >781.82

1.852

1.463–2.344

<0.001

1.412

0.955–2.090

0.084

  1. pT category pathologcial T category
  2. pN category pathologcial N category
  3. R reference
  4. ADC adenocarcinoma
  5. SCC squamous cell carcinoma
  6. PGTD pathological grading of tumor differentiation
  7. NLR neutrophil to lymphocyte ratio
  8. dNLR derived neutrophil to lymphocyte ratio
  9. PLR platelet to lymphocyte ratio
  10. LMR lymphocyte to monocyte ratio
  11. SII systematic immune-inflammation index
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us